According to the latest data from the Hong Kong Stock Exchange, on November 24, Morgan Stanley increased its stake in Hengrui Pharma (01276) by approximately 1.77 million shares at an average price of HK$69.65 per share, totaling around HK$123 million.
Following this acquisition, Morgan Stanley's total holdings in the company reached approximately 20.85 million shares, representing an 8.07% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments